Aerie Pharmaceuticals, Inc.
(NASDAQ : AERI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -2.55%123.380.0%$420.72m
ICLRICON plc 4.06%218.002.8%$327.09m
VRXValeant Pharmaceuticals International, Inc. 0.07%28.6114.1%$168.35m
HZNPHorizon Therapeutics Plc 0.98%101.055.5%$133.76m
JAZZJazz Pharmaceuticals Plc 0.06%173.932.2%$86.74m
CTLTCatalent, Inc. 0.98%116.322.1%$77.40m
PRGOPerrigo Co. Plc 1.24%46.396.9%$51.38m
UTHRUnited Therapeutics Corp. -0.66%184.5714.0%$48.05m
ENDPEndo International Plc 2.25%5.008.6%$44.90m
BHCBausch Health Cos., Inc. 0.07%28.610.0%$44.44m
ARGXargenx SE -0.16%316.090.0%$40.75m
SAGESAGE Therapeutics, Inc. -1.62%45.037.6%$34.98m
IRWDIronwood Pharmaceuticals, Inc. 0.23%13.029.6%$28.42m
ZGNXZogenix, Inc. 3.36%17.827.5%$22.55m
AXSMAxsome Therapeutics, Inc. -3.94%53.681.9%$19.90m

Company Profile

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.